Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
accrual, Alabama, AST, broader, CDMO, Chairperson, CPA, curable, departure, disbursed, eradicated, evidenced, foot, howsoever, ID, immunotherapy, inactive, influenza, IRC, LNP, Medallion, membership, nanoparticle, NeuroAirmid, OmniaBio, pain, poly, polymer, POZ, prematurely, quotient, ranking, refinance, Revere, rollforward, Serina, Signature, simple, slightly, spinoff, stipulated, subordinate, Subordination, therewith, troubled, Trust, unbonded, unvacated, vintage, wholly
Removed:
allocable, allocating, AMT, Ascendance, Atlantic, Avenue, calculating, complexity, deductibility, deposited, depreciated, designate, duly, exiting, expensing, flat, goodwill, herewith, imposing, intraperiod, ischemiam, Israeli, lowering, Mauldin, multinational, NIS, offshore, omitted, organize, ranging, repatriation, retired, Shekel, simplify, sublease, Sublessee, sublessor, taxation, taxpayer, tenant, territorial, thereunto, translated, translation, travel, unaffiliated, undersigned
Filing tables
Filing exhibits
SER similar filings
Filing view
External links
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-251988) and Form S-8 (Nos. 333-229432, 333-261997 and 333-269588) of AgeX Therapeutics, Inc. of our report dated March 31, 2023, which includes an explanatory paragraph relating to AgeX Therapeutics, Inc.’s ability to continue as a going concern, relating to the consolidated financial statements of AgeX Therapeutics, Inc., which appears in this Form 10-K.
/s/ WithumSmith+Brown, PC
San Francisco, California
March 31, 2023